HARVARD BIOSCIENCE INC (HBIO) Stock Balance Sheet
NASDAQ:HBIO - Nasdaq - US4169061052 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 4.57M | 4.28M | 4.50M | 7.80M | 8.30M | |||
| Receivables | 12.83M | 20.04M | 20.20M | 26.20M | 21.10M | |||
| Inventories | 25.99M | 24.72M | 26.40M | 27.60M | 22.30M | |||
| Other Current Assets | 3.40M | N/A | N/A | N/A | N/A | |||
| Total Current Assets | 46.79M | 49.04M | 51.10M | 61.60M | 51.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.74M | 8.75M | 9.20M | 10.30M | 11.70M | |||
| Goodwill | 57.44M | 57.06M | 56.30M | 57.70M | 58.60M | |||
| Intangibles | 12.34M | 16.04M | 21.00M | 27.40M | 33.20M | |||
| Other Non-Current Assets | 2.92M | 6.47M | 7.80M | 5.40M | 1.10M | |||
| Total Non-Current Assets | 84.45M | 88.33M | 94.30M | 100.70M | 104.60M | |||
| TOTAL ASSETS | 131.24M | 137.37M | 145.40M | 162.30M | 156.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.61M | 5.86M | 3.80M | 3.20M | 1.70M | |||
| Accrued Expenses | 8.55M | 9.38M | 8.60M | 11.20M | 7.60M | |||
| Accounts Payable | 5.28M | 5.55M | 6.40M | 4.90M | 6.00M | |||
| Other Current Liabilities | 5.31M | 5.75M | 4.40M | 6.00M | 5.80M | |||
| Total Current Liabilities | 22.75M | 26.54M | 23.20M | 25.30M | 21.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 34.25M | 30.70M | 43.00M | 45.10M | 46.30M | |||
| Deferred Taxes/Income | 707.00K | 776.00K | 600.00K | 1.60M | 1.90M | |||
| Other Non-Current Liabilities | 8.21M | 6.27M | 6.30M | 7.00M | 10.30M | |||
| Total Non-Current Liabilities | 43.17M | 37.75M | 49.90M | 53.60M | 58.50M | |||
| TOTAL LIABILITIES | 65.92M | 64.29M | 73.10M | 78.90M | 79.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -158.03M | -145.60M | -142.20M | -132.70M | -132.40M | |||
| Additional Paid In Capital | 235.97M | 232.44M | 229.00M | 225.70M | 232.40M | |||
| Common Shares | 436.00K | 434.00K | 500.00K | 500.00K | 400.00K | |||
| Treasury Stock | N/A | N/A | N/A | 0.00 | -10.70M | |||
| Other Shareholders' Equity | -13.06M | -14.19M | -15.10M | -10.00M | -13.10M | |||
| Shares Outstanding | 43.62M | 43.39M | 42.10M | 41.10M | 39.40M | |||
| Tangible Book Value per Share | -0.10 | -0.00 | -0.12 | -0.04 | -0.38 | |||
| Total Shareholders' Equity | 65.32M | 73.07M | 72.20M | 83.40M | 76.70M | |||
| TOTAL LIABILITIES AND EQUITY | 131.24M | 137.37M | 145.40M | 162.30M | 156.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.52 | 0.42 | 0.60 | 0.54 | 0.60 | |||
| Current Ratio | 2.06 | 1.85 | 2.20 | 2.43 | 2.45 | |||
| Return On Assets (ROA) | -10.85% | -2.49% | -6.53% | -0.18% | -4.99% | |||
| Return On Equity (ROE) | -21.80% | -4.67% | -13.16% | -0.36% | -10.17% | |||
| Return On Invested Capital (ROIC) | N/A | 1.63% | N/A | 1.96% | 0.12% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 1.69% | N/A | 2.08% | 0.12% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 5.40% | N/A | 6.09% | 0.45% | |||
All data in USD , ROIC based on taxRate of 0.21